Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies (vol 15, 1477101, 2024)

被引：0
|
作者：
O'Donovan, Alexander J. [1 ]
Gorelik, Seth [1 ,2 ]
Nally, Laura M. [1 ]
机构：
[1] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA
[2] Bowdoin Coll, Brunswick, ME USA
来源：
FRONTIERS IN ENDOCRINOLOGY | 2025年 / 15卷
关键词：
type; 1; diabetes; stage; 2; 3; teplizumab; disease-modifying therapies;
D O I：
10.3389/fendo.2024.1548761
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 9 条
  • [1] Shifting the paradigm of type 1 diabetes: a narrative review of disease modifying therapies
    O'Donovan, Alexander J.
    Gorelik, Seth
    Nally, Laura M.
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [2] New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
    Nagy, Geza
    Szekely, Tekla Evelin
    Somogyi, Aniko
    Herold, Magdolna
    Herold, Zoltan
    WORLD JOURNAL OF DIABETES, 2022, 13 (10) : 835 - 850
  • [3] Current perspectives and the future of disease-modifying therapies in type 1 diabetes
    Mondal, Sunetra
    Pappachan, Joseph M.
    WORLD JOURNAL OF DIABETES, 2025, 16 (01)
  • [4] Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes
    Shapiro, Melanie R.
    Tallon, Erin M.
    Brown, Matthew E.
    Posgai, Amanda L.
    Clements, Mark A.
    Brusko, Todd M.
    DIABETOLOGIA, 2025, 68 (03) : 477 - 494
  • [5] The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis
    Lin, Chu
    Hu, Suiyuan
    Cai, Xiaoling
    Lv, Fang
    Yang, Wenjia
    Liu, Geling
    Yang, Xiaolin
    Ji, Linong
    PHARMACOLOGICAL RESEARCH, 2024, 203
  • [6] Incorporating patients' preferences in the value assessment of disease-modifying therapies for multiple sclerosis: a narrative review
    Ngorsuraches, Surachat
    Poudel, Nabin
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (02) : 183 - 195
  • [7] The shifting paradigm of a "cure" for type 1 diabetes: is technology replacing immune-based therapies?
    Pettus, Jeremy
    Von Herrath, Matthias
    ACTA DIABETOLOGICA, 2018, 55 (02) : 117 - 120
  • [8] Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going?
    Lord, Sandra
    Greenbaum, Carla J.
    PHARMACOLOGICAL RESEARCH, 2015, 98 : 3 - 8
  • [9] A Narrative Review of Celiac Disease in India with a Focus on its Link with Type 1 Diabetes
    Tharunika, Sridhar
    Mohan, Viswanathan
    Anjana, Ranjit Mohan
    Amutha, Anandakumar
    JOURNAL OF DIABETOLOGY, 2025, 16 (01) : 14 - 21
1